UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
PUT
Nike
NKE
$58.8B
| $22.1M | ﹤0.01% |
537,600
-262,500
| -33% | -$11.5M |
2014 Q4
46 quarters
|
|
2577
Enerflex
EFXT
$2.5B
| $22M | ﹤0.01% |
899,416
-200,293
| -18% | -$5M |
2022 Q4
14 quarters
|
|
2578
SM Energy
SM
$6.96B
| $22M | ﹤0.01% |
844,527
-1,235,321
| -59% | -$37.1M |
2014 Q4
46 quarters
|
|
2579
Alamos Gold
AGI
$13B
| $22M | ﹤0.01% |
725,814
+161,215
| +29% | +$6.53M |
2014 Q4
46 quarters
|
|
2580
Ultragenyx Pharmaceutical
RARE
$1.59B
| $22M | ﹤0.01% |
657,699
-175,041
| -21% | -$4.35M |
2014 Q4
46 quarters
|
|
2581
Comstock Resources
CRK
$3.91B
| $22M | ﹤0.01% |
1,471,612
+203,097
| +16% | +$3.1M |
2019 Q2
28 quarters
|
|
2582
Harmony Biosciences
HRMY
$1.91B
| $22M | ﹤0.01% |
602,990
+154,999
| +35% | +$4.89M |
2020 Q3
23 quarters
|
|
2583
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.8B
| $21.9M | ﹤0.01% |
42,000
+25,000
| +147% | +$12.5M |
2016 Q4
38 quarters
|
|
2584
Howard Hughes
HHH
$4.66B
| $21.9M | ﹤0.01% |
306,291
+86,558
| +39% | +$5.63M |
2014 Q4
46 quarters
|
|
2585
Gold Fields
GFI
$33.7B
| $21.9M | ﹤0.01% |
651,715
+223,340
| +52% | +$9.3M |
2014 Q4
46 quarters
|
|
2586
CALL
Okta
OKTA
$29.9B
| $21.9M | ﹤0.01% |
160,408
-44,500
| -22% | -$4.18M |
2021 Q3
19 quarters
|
|
2587
iShares Future Exponential Technologies ETF
XT
$3.78B
| $21.9M | ﹤0.01% |
264,698
-17,993
| -6% | -$1.41M |
2016 Q4
38 quarters
|
|
|
DMRA
2588
Damora Therapeutics
DMRA
$1.42B
| $21.9M | ﹤0.01% |
840,292
+679,877
| +424% | +$16.5M |
2024 Q3
7 quarters
|
|
2589
CALL
BHP
BHP
$200B
| $21.8M | ﹤0.01% |
261,400
-119,400
| -31% | -$9.9M |
2023 Q3
11 quarters
|
|
2590
Invesco S&P 500 Equal Weight Income Advantage ETF
RSPA
$1.24B
| $21.7M | ﹤0.01% |
407,224
+154,417
| +61% | +$8.06M |
2025 Q3
3 quarters
|
|
2591
State Street SPDR NYSE Technology ETF
XNTK
$1.59B
| $21.7M | ﹤0.01% |
55,604
+3,143
| +6% | +$1.05M |
2014 Q4
46 quarters
|
|
2592
PUT
Agnico Eagle Mines
AEM
$95.6B
| $21.7M | ﹤0.01% |
140,000
-103,700
| -43% | -$19.2M |
2020 Q4
22 quarters
|
|
2593
First Trust Health Care AlphaDEX Fund
FXH
$1.17B
| $21.7M | ﹤0.01% |
177,248
+59,558
| +51% | +$6.83M |
2014 Q4
46 quarters
|
|
2594
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$43.5B
| $21.7M | ﹤0.01% |
229,400
-1,111,400
| -83% | -$105M |
2026 Q1
1 quarter
|
|
2595
Primerica
PRI
$8.89B
| $21.7M | ﹤0.01% |
76,222
+1,893
| +3% | +$518K |
2014 Q4
46 quarters
|
|
2596
ProShares Ultra S&P500
SSO
$7.93B
| $21.7M | ﹤0.01% |
321,453
+36,711
| +13% | +$2.35M |
2022 Q2
16 quarters
|
|
2597
PUT
Lennar Class A
LEN
$21.8B
| $21.6M | ﹤0.01% |
239,245
| – | – |
2023 Q2
12 quarters
|
|
2598
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$3.44B
| $21.6M | ﹤0.01% |
202,250
-47,110
| -19% | -$5.53M |
2023 Q4
10 quarters
|
|
2599
Fidelity Limited Term Bond ETF
FLTB
$491M
| $21.6M | ﹤0.01% |
430,243
-21,066
| -5% | -$1.06M |
2018 Q1
33 quarters
|
|
2600
DBV Technologies S.A. American Depositary Shares
DBVT
$625M
| $21.5M | ﹤0.01% |
1,313,439
+1,233,902
| +1,551% | +$23.3M |
2024 Q4
6 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.